Abivax S.A. Increase Decrease Through Exercise Of Warrants Equity
Abivax S.A. (ABVX) had Increase Decrease Through Exercise Of Warrants Equity of EUR 11.53 million as of 2025-08-28, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2026-03-23
- Abivax S.A. increase decrease through exercise of warrants equity for the quarter ending 2024-12-31 was 0.00 EUR.
- Abivax S.A. increase decrease through exercise of warrants equity for the quarter ending 2024-09-30 was 0.00 EUR.
| Period end | Increase Decrease Through Exercise Of Warrants Equity | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 9 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|---|---|
| 2025-08-28 | 11.53M EUR 20-F · filed 2026-03-23 | ||||
| 2025-07-30 | 15.14M EUR 20-F · filed 2026-03-23 | ||||
| 2024-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 0.00 EUR derived: sum of 2 quarters · filed 2026-03-23 | 45.00K EUR 20-F · filed 2026-03-23 | ||
| 2024-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 45.00K EUR 6-K · filed 2025-12-15 | |||
| 2024-06-30 | 45.00K EUR 6-K · filed 2025-09-08 | ||||
| 2023-05-24 | 1.85M EUR 20-F · filed 2025-03-24 | ||||
| 2022-12-31 | 3.00K EUR 20-F · filed 2025-03-24 |